Benjamin Vandendriessche, PhD, Chief Executive Officer of the Digital Medicine Society (DiMe)
Medical Affairs Professional Society hosts Technology and Innovation Symposium on October 15, featuring Digital Medicine Society CEO Benjamin Vandendriessche.
AI is changing what physicians, payers, and patients expect from Medical Affairs, and the profession has a real opportunity to lead that change.”— Travis Hege, CEO of MAPSBOSTON, MA, UNITED STATES, October 2, 2026 /EINPresswire.com/ — With artificial intelligence transitioning from experimental initiatives into routine operations throughout the life sciences sector, the Medical Affairs Professional Society (MAPS) is assembling executives from pharmaceutical, biotechnology, and medical technology companies for the 2026 Medical Affairs Technology and Innovation Symposium on Thursday, October 15, at One Boston Place in downtown Boston. REGISTRATION IS NOW OPEN.
Organized by the MAPS New England Chapter and backed by sponsors Indegene and ACTO, this symposium will explore how Medical Affairs teams can leverage AI, digital health tools, and data science to boost value for physicians, patients, and their own organizations—while doing so in an ethical manner.
"AI is changing what physicians, payers, and patients expect from Medical Affairs, and the profession has a real opportunity to lead that change," says Travis Hege, CEO of MAPS. “This symposium brings together the people who are already putting these tools to work, so attendees leave with practical insight they can apply right away."
The event kicks off with a keynote address from Benjamin Vandendriessche, PhD, Chief Executive Officer of the Digital Medicine Society (DiMe), titled "Realizing the Promise of Digital Health: From Innovation to the Sustainable Transformation of Medicine."
Two Expert Panels on AI in Medical Affairs:
– From Promise to Performance: AI at Scale in Medical Affairs explores what it takes to move AI beyond pilots and into daily practice.
– Leading into the Future: Ethical Use Cases for AI and Data Science in Medical Affairs addresses the governance, transparency and ethical questions every Medical Affairs leader now faces.
Featured Panelists:
– Elnaz Alipour, Senior Director, Medical Analytics, Pfizer
– Gary Fanjiang, VP, US Medical Affairs, Amgen
– Lee Gervitz, Senior VP, Medical Affairs, Xenon Pharmaceuticals
– Parth Khanna, CEO and Founder, ACTO
– Jully Kim, Senior Director, Global Medical Operations, CSL
– Antonia Panayi, Head of Global Medical Evidence, Takeda
– Gem Roy, Associate Director, AI Enablement, Merck
The day wraps up with a networking reception, offering attendees a chance to connect with speakers and colleagues from across the Boston life sciences ecosystem.
Event Details:
– Date: Thursday, October 15, 2026
– Time: 12:30 – 7:30 PM ET
– Location: One Boston Place, 201 Washington Street, Boston, MA 02108
Open to MAPS members and non-members, with discounted rates for students.
About the Medical Affairs Professional Society (MAPS)
Founded in 2016, the Medical Affairs Professional Society (MAPS) is a 501(c)(3) non-profit organization and the global authority for Medical Affairs professionals, connecting over 18,000 members worldwide across pharmaceuticals, biotech, MedTech, and affiliated organizations. MAPS empowers professionals at every career stage, from emerging professionals to executive leaders, through world-class education, research-driven insights, expert-led events, and a global community dedicated to advancing the field and shaping its future. Learn more at MedicalAffairs.org.
Craig Ruvere
Medical Affairs Professional Society
cruvere@medicalaffairs.org
Visit us on social media:
LinkedIn
YouTube
Also worth a look: Mitolyn, Built Around the Purple Peel Exploit, has been Launched, Designed to Enhance Mitochondrial Health & Manage Weight and Out Today: “My Favorite Things” by Award-winning Vocalist Nicole Henry.
